女性乳腺癌患者,乳房切除术相关的生活质量:来自埃塞俄比亚的经验。

IF 1.6 Q4 ONCOLOGY
International Journal of Breast Cancer Pub Date : 2020-04-09 eCollection Date: 2020-01-01 DOI:10.1155/2020/8460374
Engida Abebe, Kassaw Demilie, Befekadu Lemmu, Kirubel Abebe
{"title":"女性乳腺癌患者,乳房切除术相关的生活质量:来自埃塞俄比亚的经验。","authors":"Engida Abebe,&nbsp;Kassaw Demilie,&nbsp;Befekadu Lemmu,&nbsp;Kirubel Abebe","doi":"10.1155/2020/8460374","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mastectomy is the most common form of treatment for a developing-nation woman diagnosed with breast cancer. This can have huge effect on a women's quality of life.</p><p><strong>Objective: </strong>To assess mastectomy-related quality of life in female breast cancer patients.</p><p><strong>Materials and methods: </strong>A facility-based cross-sectional descriptive study was conducted from February 1<sup>st</sup> to July 30<sup>th</sup>, 2018. A pretested structured data collection format was used to interview patients. The European Organization for Research and Treatment for Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and Breast Cancer-Specific (EORTC QLQ-BR23) were used to evaluate quality of life, functional capacity, and symptom scales. Data was analyzed with SPSS version 23.</p><p><strong>Results: </strong>The mean age of the 86 patients was 43.2 years (SD ± 11.4) and ranged from 25 to 70 years. 54.7% (47) of patient's mastectomy was done on the right side. Based on EORTC QLQ-C30 global health status/QOL scale, the mean score was 48.3. On the evaluation of EORTC QLQ-BR23, future perspective about their health was low with a mean of 40.3 and their sexual functioning and enjoyment were significantly affected with mean scores of 85.3 and 71.2, respectively. Symptom scales were low with mean from 19.1 to 24.5. Majority (49, 57%) of respondents do not want to have breast reconstruction after mastectomy.</p><p><strong>Conclusion: </strong>Our breast cancer patients who underwent mastectomy performed poor in terms of quality of life as compared to international findings which demands attention in incorporating psychosocial aspects in the treatment plan.</p>","PeriodicalId":46159,"journal":{"name":"International Journal of Breast Cancer","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2020-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8460374","citationCount":"8","resultStr":"{\"title\":\"Female Breast Cancer Patients, Mastectomy-Related Quality of Life: Experience from Ethiopia.\",\"authors\":\"Engida Abebe,&nbsp;Kassaw Demilie,&nbsp;Befekadu Lemmu,&nbsp;Kirubel Abebe\",\"doi\":\"10.1155/2020/8460374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Mastectomy is the most common form of treatment for a developing-nation woman diagnosed with breast cancer. This can have huge effect on a women's quality of life.</p><p><strong>Objective: </strong>To assess mastectomy-related quality of life in female breast cancer patients.</p><p><strong>Materials and methods: </strong>A facility-based cross-sectional descriptive study was conducted from February 1<sup>st</sup> to July 30<sup>th</sup>, 2018. A pretested structured data collection format was used to interview patients. The European Organization for Research and Treatment for Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and Breast Cancer-Specific (EORTC QLQ-BR23) were used to evaluate quality of life, functional capacity, and symptom scales. Data was analyzed with SPSS version 23.</p><p><strong>Results: </strong>The mean age of the 86 patients was 43.2 years (SD ± 11.4) and ranged from 25 to 70 years. 54.7% (47) of patient's mastectomy was done on the right side. Based on EORTC QLQ-C30 global health status/QOL scale, the mean score was 48.3. On the evaluation of EORTC QLQ-BR23, future perspective about their health was low with a mean of 40.3 and their sexual functioning and enjoyment were significantly affected with mean scores of 85.3 and 71.2, respectively. Symptom scales were low with mean from 19.1 to 24.5. Majority (49, 57%) of respondents do not want to have breast reconstruction after mastectomy.</p><p><strong>Conclusion: </strong>Our breast cancer patients who underwent mastectomy performed poor in terms of quality of life as compared to international findings which demands attention in incorporating psychosocial aspects in the treatment plan.</p>\",\"PeriodicalId\":46159,\"journal\":{\"name\":\"International Journal of Breast Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2020-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2020/8460374\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Breast Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/8460374\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Breast Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8460374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 8

摘要

背景:乳房切除术是发展中国家诊断为乳腺癌的妇女最常见的治疗形式。这对女性的生活质量有很大的影响。目的:评价女性乳腺癌患者行乳房切除术后的生活质量。材料和方法:于2018年2月1日至7月30日进行基于设施的横断面描述性研究。采用预先测试的结构化数据收集格式对患者进行访谈。采用欧洲癌症研究与治疗组织生活质量问卷- core 30 (EORTC QLQ-C30)和乳腺癌特异性问卷(EORTC QLQ-BR23)评估生活质量、功能能力和症状量表。数据分析采用SPSS version 23。结果:86例患者平均年龄43.2岁(SD±11.4),年龄25 ~ 70岁。54.7%(47)的患者右侧乳房切除术。根据EORTC QLQ-C30全球健康状态/生活质量量表,平均得分为48.3分。在EORTC QLQ-BR23评价中,女性对健康的未来展望较低,平均得分为40.3分,对性功能和性享受的影响显著,平均得分分别为85.3分和71.2分。症状量表较低,平均值为19.1 ~ 24.5。大多数受访者(49.57%)不希望在乳房切除术后进行乳房重建。结论:与国际研究结果相比,我国接受乳房切除术的乳腺癌患者的生活质量较差,这需要在治疗计划中纳入心理社会方面的关注。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Female Breast Cancer Patients, Mastectomy-Related Quality of Life: Experience from Ethiopia.

Female Breast Cancer Patients, Mastectomy-Related Quality of Life: Experience from Ethiopia.

Female Breast Cancer Patients, Mastectomy-Related Quality of Life: Experience from Ethiopia.

Background: Mastectomy is the most common form of treatment for a developing-nation woman diagnosed with breast cancer. This can have huge effect on a women's quality of life.

Objective: To assess mastectomy-related quality of life in female breast cancer patients.

Materials and methods: A facility-based cross-sectional descriptive study was conducted from February 1st to July 30th, 2018. A pretested structured data collection format was used to interview patients. The European Organization for Research and Treatment for Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and Breast Cancer-Specific (EORTC QLQ-BR23) were used to evaluate quality of life, functional capacity, and symptom scales. Data was analyzed with SPSS version 23.

Results: The mean age of the 86 patients was 43.2 years (SD ± 11.4) and ranged from 25 to 70 years. 54.7% (47) of patient's mastectomy was done on the right side. Based on EORTC QLQ-C30 global health status/QOL scale, the mean score was 48.3. On the evaluation of EORTC QLQ-BR23, future perspective about their health was low with a mean of 40.3 and their sexual functioning and enjoyment were significantly affected with mean scores of 85.3 and 71.2, respectively. Symptom scales were low with mean from 19.1 to 24.5. Majority (49, 57%) of respondents do not want to have breast reconstruction after mastectomy.

Conclusion: Our breast cancer patients who underwent mastectomy performed poor in terms of quality of life as compared to international findings which demands attention in incorporating psychosocial aspects in the treatment plan.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.40
自引率
0.00%
发文量
25
审稿时长
19 weeks
期刊介绍: International Journal of Breast Cancer is a peer-reviewed, Open Access journal that provides a forum for scientists, clinicians, and health care professionals working in breast cancer research and management. The journal publishes original research articles, review articles, and clinical studies related to molecular pathology, genomics, genetic predisposition, screening and diagnosis, disease markers, drug sensitivity and resistance, as well as novel therapies, with a specific focus on molecular targeted agents and immune therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信